MID2 and cancer: Compared with other E3 ligases that can either promote HIF1α’s degradation or stabilization, TRIM1 activates HIF-1α signaling by promoting its nuclear translocations instead of influencing the expression level, expanding the role of HIF1α ubiquitination in cancer.